Recently, Charles River Laboratories—a provider of products and services for drug research and development—presented a webinar about starting material for manufacturing cell therapies. Scott R. Burger ...
Induced pluripotent stem cells (iPSCs) are a “starting material grail” for advanced therapies. That’s according to Sven Kili, chief development officer at CCRM, the Canadian regenerative medicine ...
100% starting materials identification testing is a requirement according to the US FDA’s directive 211.84 for FDA-regulated industries such as Vaccines, Tobacco, Pharmaceutical, Food, Cosmetics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results